Jens Eckstein

Jens Eckstein has extensive work experience in the biotech industry. Jens currently serves as the Managing Partner at Apollo Health Ventures and is a Member of the Board of Directors and President at Galilei Biosciences. In addition, they are an Advisor at Thymofox, Inc., and an Advisor and Chairman at Booster Therapeutics. Jens Eckstein also holds positions as a Member of the Board of Directors and Interim Chairman at HAYA Therapeutics SA, an Angel Investor and Member of the Board of Directors at bosWell, and an Advisor and Member of the Board of Directors at Cleara Biotech. Jens is also involved in Aeovian Pharmaceuticals as a Member of the Board of Directors and Chairman of the Board. Previously, Jens Eckstein has served as the President and Chairman of the Board and Interim CEO at Samsara Therapeutics and as a Non-Executive Director at Imugene Limited. Overall, they have a diverse range of roles and responsibilities within the biotech industry.

Jens Eckstein completed their education in a chronological order. Jens first attended Bildungszentrum Markdorf (BZM) from 1974 to 1982, where they obtained a Baccalaureate degree in Life in General. After that, they enrolled at the University of Konstanz and pursued a Diplom in Chemistry, which they completed from 1982 to 1987. Following this, Jens continued their studies at the University of Konstanz and Harvard University, obtaining a Ph.D. in Biological Chemistry between 1987 and 1991. Lastly, they pursued a Postdoctoral Fellowship in Enzyme Mechanisms and Drug Design at the University of California, San Francisco from 1991 to 1993.